Suppr超能文献

磷酸甘油酸脱氢酶的催化和别构机制对比。

Contrasting catalytic and allosteric mechanisms for phosphoglycerate dehydrogenases.

机构信息

Department of Developmental Biology, Washington University School of Medicine, 660 S. Euclid Avenue, Box 8103, St. Louis, MO 63110, USA.

出版信息

Arch Biochem Biophys. 2012 Mar 15;519(2):175-85. doi: 10.1016/j.abb.2011.10.005. Epub 2011 Oct 15.

Abstract

D-3-Phosphoglycerate dehydrogenases (PGDH) exist with at least three different structural motifs and the enzymes from different species display distinctly different mechanisms. In many species, particularly bacteria, the catalytic activity is regulated allosterically through binding of l-serine to a distinct structural domain, termed the ACT domain. Some species, such as Mycobacterium tuberculosis, contain an additional domain, called the "allosteric substrate binding" or ASB domain, that functions as a co-domain in the regulation of catalytic activity. That is, both substrate and effector function synergistically in the regulation of activity to give the enzyme some interesting properties that may have physiological relevance for the persistent state of tuberculosis. Both enzymes function through a V-type regulatory mechanism and, in the Escherichia coli enzyme, it has been demonstrated that this results from a dead-end complex that decreases the concentration of active species rather than a decrease in the velocity of the active species. This review compares and contrasts what we know about these enzymes and provides additional insight into their mechanism of allosteric regulation.

摘要

D-3-磷酸甘油酸脱氢酶 (PGDH) 至少存在三种不同的结构基序,不同物种的酶表现出明显不同的机制。在许多物种中,特别是细菌,通过 l-丝氨酸结合到一个称为 ACT 结构域的独特结构域,对催化活性进行别构调节。一些物种,如结核分枝杆菌,含有一个称为“别构底物结合”或 ASB 结构域的附加结构域,在调节催化活性中作为协同结构域发挥作用。也就是说,底物和效应物协同作用调节活性,使酶具有一些有趣的特性,这些特性可能与结核病的持续状态具有生理相关性。两种酶都通过 V 型调节机制发挥作用,在大肠杆菌酶中,已经证明这是由于终产物复合物的形成降低了活性物质的浓度,而不是降低了活性物质的速度。本综述比较和对比了我们对这些酶的了解,并提供了对其别构调节机制的深入了解。

相似文献

1
Contrasting catalytic and allosteric mechanisms for phosphoglycerate dehydrogenases.
Arch Biochem Biophys. 2012 Mar 15;519(2):175-85. doi: 10.1016/j.abb.2011.10.005. Epub 2011 Oct 15.
9
Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase.
Biochemistry. 2008 Aug 12;47(32):8271-82. doi: 10.1021/bi800212b. Epub 2008 Jul 16.
10
D-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberculosis is a link between the Escherichia coli and mammalian enzymes.
J Biol Chem. 2005 Apr 15;280(15):14884-91. doi: 10.1074/jbc.M414488200. Epub 2005 Jan 24.

引用本文的文献

2
Protein post-translational modifications in serine synthetic pathway: functions and molecular mechanisms.
Cell Commun Signal. 2025 Jul 1;23(1):311. doi: 10.1186/s12964-025-02327-4.
3
Transcriptional regulation by PHGDH drives amyloid pathology in Alzheimer's disease.
Cell. 2025 Jun 26;188(13):3513-3529.e26. doi: 10.1016/j.cell.2025.03.045. Epub 2025 Apr 23.
4
Structural insights into the catalytic mechanism of the microcystin tailoring enzyme McyI.
Commun Biol. 2025 Apr 7;8(1):578. doi: 10.1038/s42003-025-08008-9.
5
On the quaternary structure of human D-3-phosphoglycerate dehydrogenase.
Protein Sci. 2024 Aug;33(8):e5089. doi: 10.1002/pro.5089.
6
PHGDH: a novel therapeutic target in cancer.
Exp Mol Med. 2024 Jul;56(7):1513-1522. doi: 10.1038/s12276-024-01268-1. Epub 2024 Jul 1.
7
Insight into de-regulation of amino acid feedback inhibition: a focus on structure analysis method.
Microb Cell Fact. 2023 Aug 23;22(1):161. doi: 10.1186/s12934-023-02178-z.
9
Revealing a New Family of D-2-Hydroxyglutarate Dehydrogenases in and Encoded by .
Microorganisms. 2022 Aug 31;10(9):1766. doi: 10.3390/microorganisms10091766.
10
Directed Evolution of ()-2-Hydroxyglutarate Dehydrogenase Improves 2-Oxoadipate Reduction by 2 Orders of Magnitude.
ACS Synth Biol. 2022 Aug 19;11(8):2779-2790. doi: 10.1021/acssynbio.2c00162. Epub 2022 Aug 8.

本文引用的文献

1
Kinetic, mutagenic, and structural homology analysis of L-serine dehydratase from Legionella pneumophila.
Arch Biochem Biophys. 2011 Nov;515(1-2):28-36. doi: 10.1016/j.abb.2011.08.005. Epub 2011 Aug 23.
5
A stopped flow transient kinetic analysis of substrate binding and catalysis in Escherichia coli D-3-phosphoglycerate dehydrogenase.
J Biol Chem. 2008 Oct 31;283(44):29706-14. doi: 10.1074/jbc.M805180200. Epub 2008 Sep 6.
6
Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase.
Biochemistry. 2008 Aug 12;47(32):8271-82. doi: 10.1021/bi800212b. Epub 2008 Jul 16.
7
A novel mechanism for substrate inhibition in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase.
J Biol Chem. 2007 Oct 26;282(43):31517-24. doi: 10.1074/jbc.M704032200. Epub 2007 Aug 30.
8
The ACT domain: a small molecule binding domain and its role as a common regulatory element.
J Biol Chem. 2006 Nov 10;281(45):33825-9. doi: 10.1074/jbc.R600024200. Epub 2006 Sep 20.
10
D-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberculosis is a link between the Escherichia coli and mammalian enzymes.
J Biol Chem. 2005 Apr 15;280(15):14884-91. doi: 10.1074/jbc.M414488200. Epub 2005 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验